STEM-Talk Episode 118: Julie Andersen talks about urolithin-A’s potential to prevent and treat neurodegenerative diseases
and thought it was fairly interesting.
I also liked their part 1 interview with Julie, although it had less emphasis on AD.Today we have part two of our conversation with Dr. Julie Andersen, a professor at the Buck Institute who is conducting fascinating research into the metabolite compound urolithin-A.
Laboratory experiments have demonstrated urolithin-A’s ability to induce mitophagy, which is a selective recycling of mitochondria by autophagy, a process that cleans defective mitochondria and becomes less efficient during aging. Julie’s research has focused on the potential of urolithin-A to prevent and treat such diseases such as Alzheimer’s, Parkinson’s, Huntington’s and Lou Gehrig’s disease.
During the podcast, they briefly discuss a uolithin-A product from Mitopure available in the US from Timeline Nutrition. As you'd probably expect, it's not inexpensive.